Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
The European Respiratory Journal
|
May 23, 2009
Taurolidine and oxidative stress: a rationale for local treatment of mesothelioma
N Aceto, P Bertino, D Barbone, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace
|
August 5, 1998
Recurrent chromosome 6 abnormalities in malignant mesothelioma
M Ribotta, F Roseo, M Salvio, et al.
The European Respiratory Journal
|
September 1, 1995
Blood cell redistribution in the lung after administration of recombinant human granulocyte-macrophage colony-stimulating factor
E Gatti, G V Scagliotti, G Ferrari, et al.
Leukemia
|
April 1, 1995
In vivo effect of human granulocyte-macrophage colony-stimulating factor (GM-CSF) on neutrophil GM-CSF receptors
A Stacchini, L Fubini, E Gatti, et al.
The Journal of Pathology
|
May 17, 2002
Expression of glycoprotein 90K in human malignant pleural mesothelioma: correlation with patient survival
L Strizzi, R Muraro, G Vianale, et al.
Genes, Chromosomes & Cancer
|
August 26, 2000
Simian virus-40 sequences are a negative prognostic cofactor in patients with malignant pleural mesothelioma
A Procopio, L Strizzi, G Vianale, et al.
The Journal of Pathology
|
March 29, 2001
Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma
L Strizzi, A Catalano, G Vianale, et al.
Developments in Biological Standardization
|
October 17, 1998
Evidence for and implications of SV40-like sequences in human mesotheliomas and osteosarcomas
P Rizzo, I Di Resta, R Stach, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace
|
August 5, 1998
The biological activities of simian virus 40 large-T antigen and its possible oncogenic effects in humans
C M Matker, P Rizzo, H I Pass, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 13, 2001
Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion: Results of a phase II study on 31 consecutive patients
B Castagneto, S Zai, L Mutti, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
The European Respiratory Journal
|
May 23, 2009
Taurolidine and oxidative stress: a rationale for local treatment of mesothelioma
N Aceto, P Bertino, D Barbone, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace
|
August 5, 1998
Recurrent chromosome 6 abnormalities in malignant mesothelioma
M Ribotta, F Roseo, M Salvio, et al.
The European Respiratory Journal
|
September 1, 1995
Blood cell redistribution in the lung after administration of recombinant human granulocyte-macrophage colony-stimulating factor
E Gatti, G V Scagliotti, G Ferrari, et al.
Leukemia
|
April 1, 1995
In vivo effect of human granulocyte-macrophage colony-stimulating factor (GM-CSF) on neutrophil GM-CSF receptors
A Stacchini, L Fubini, E Gatti, et al.
The Journal of Pathology
|
May 17, 2002
Expression of glycoprotein 90K in human malignant pleural mesothelioma: correlation with patient survival
L Strizzi, R Muraro, G Vianale, et al.
Genes, Chromosomes & Cancer
|
August 26, 2000
Simian virus-40 sequences are a negative prognostic cofactor in patients with malignant pleural mesothelioma
A Procopio, L Strizzi, G Vianale, et al.
The Journal of Pathology
|
March 29, 2001
Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma
L Strizzi, A Catalano, G Vianale, et al.
Developments in Biological Standardization
|
October 17, 1998
Evidence for and implications of SV40-like sequences in human mesotheliomas and osteosarcomas
P Rizzo, I Di Resta, R Stach, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace
|
August 5, 1998
The biological activities of simian virus 40 large-T antigen and its possible oncogenic effects in humans
C M Matker, P Rizzo, H I Pass, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 13, 2001
Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion: Results of a phase II study on 31 consecutive patients
B Castagneto, S Zai, L Mutti, et al.
Page
of 4